Protection Induced by Plasmodium falciparum MSP142 Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses
2008

Strain-Specific Protection Induced by Plasmodium falciparum MSP142 Vaccine

Sample size: 27 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lyon Jeffrey A., Angov Evelina, Fay Michael P., Sullivan JoAnn S., Girourd Autumn S., Robinson Sally J., Bergmann-Leitner Elke S., Duncan Elizabeth H., Darko Christian A., Collins William E., Long Carole A., Barnwell John W.

Primary Institution: Walter Reed Army Institute of Research

Hypothesis

Does vaccination with Plasmodium falciparum MSP142 induce a protective immune response against malaria?

Conclusion

The study found that the protective effects of vaccination are strain-specific and depend on the combination of adjuvant and antigen used.

Supporting Evidence

  • Vaccination with MSP142/FA protected Aotus monkeys against malaria.
  • Protection was strain-specific, with different responses to various MSP142 alleles.
  • Adjuvant choice significantly influenced the immune response and treatment outcomes.

Takeaway

This study shows that a malaria vaccine can protect monkeys from infection, but it only works for certain strains of the malaria parasite.

Methodology

Aotus monkeys were vaccinated with different combinations of MSP142 antigens and adjuvants, then challenged with P. falciparum.

Potential Biases

Potential bias due to the small sample size and specific strain focus.

Limitations

The study's design did not allow for a balanced comparison of all antigens and adjuvants.

Participant Demographics

Aotus nancymaae monkeys were used in the study.

Statistical Information

P-Value

0.00046

Confidence Interval

(1.96, 115.2)

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0002830

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication